EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
3.4.22.27 | (4-methyl-7-[[(2S)-2-(4-[(1S)-1-(4-methylcyclohexyl)-1-[(thiophen-3-ylcarbonyl)amino]ethyl]-1H-1,2,3-triazol-1-yl)hexanoyl]amino]-2-oxo-2H-chromen-3-yl)acetic acid + H2O |
- |
Homo sapiens |
? |
- |
? |
3.4.22.27 | (7-methoxycoumarin-4-yl)-acetyl-GRWHPMGAPWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2 + H2O |
specific substrate for CatS |
Homo sapiens |
(7-methoxycoumarin-4-yl)-acetyl-GRWHPMG + APWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2 |
- |
? |
3.4.22.27 | (7-methoxycoumarin-4-yl)-acetyl-GRWPPMGLPWEK(2,4-dinitrophenyl)-D-Arg-NH2 + H2O |
specific substrate for CatS |
Homo sapiens |
(7-methoxycoumarin-4-yl)-acetyl-GRWPPMG + LPWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2 |
- |
? |
3.4.22.27 | (7-[[(2S)-2-(4-[(1S)-1,2-dimethyl-1-[(phenylcarbonyl)amino]propyl]-1H-1,2,3-triazol-1-yl)hexanoyl]amino]-4-methyl-2-oxo-2H-chromen-3-yl)acetic acid + H2O |
- |
Homo sapiens |
? |
- |
? |
3.4.22.27 | (7-[[(2S)-2-(4-[(1S)-1,2-dimethyl-1-[(thiophen-3-ylcarbonyl)amino]propyl]-1H-1,2,3-triazol-1-yl)hexanoyl]amino]-4-methyl-2-oxo-2H-chromen-3-yl)acetic acid + H2O |
- |
Homo sapiens |
? |
- |
? |
3.4.22.27 | (7-[[(2S)-2-(4-[(1S)-1-cyclohexyl-1-[(phenylcarbonyl)amino]ethyl]-1H-1,2,3-triazol-1-yl)hexanoyl]amino]-4-methyl-2-oxo-2H-chromen-3-yl)acetic acid + H2O |
- |
Homo sapiens |
? |
- |
? |
3.4.22.27 | (7-[[(2S)-2-(4-[(1S)-1-cyclohexyl-1-[(thiophen-3-ylcarbonyl)amino]ethyl]-1H-1,2,3-triazol-1-yl)hexanoyl]amino]-4-methyl-2-oxo-2H-chromen-3-yl)acetic acid + H2O |
- |
Homo sapiens |
? |
- |
? |
3.4.22.27 | (benzyloxycarbonyl-Phe-Arg)2-rhodamine 110 + H2O |
- |
Homo sapiens |
? |
- |
? |
3.4.22.27 | 10 kDa fragment of the lysosomal MHCII-bound invariant chain + H2O |
li p10 |
Homo sapiens |
class II associated invariant chain peptide fragments |
- |
? |
3.4.22.27 | Ac-His-Pro-Val-Lys-7-amido-3-carbamoylmethyl-4-methylcoumarin + H2O |
assay at pH 5.5, 37°C |
Homo sapiens |
Ac-His-Pro-Val-Lys + 7-amino-3-carbamoylmethyl-4-methylcoumarin |
- |
? |